Breast cancer drug could be used to treat life-threatening leukaemia
A recently-approved breast cancer drug could be used to target and treat a life-threatening leukaemia, new research has revealed.
Oct 9, 2018
0
26
A recently-approved breast cancer drug could be used to target and treat a life-threatening leukaemia, new research has revealed.
Oct 9, 2018
0
26
A cancer immunotherapy has been provisionally rejected as a treatment for some adults with an aggressive type of non-Hodgkin lymphoma on the NHS in England.
Sep 19, 2018
0
3
Chemotherapy often gets a bad reputation – mainly down to the side effects it can cause.
Sep 14, 2018
0
2
For 40 years, researchers have believed there is an increased risk of cancer associated with styrene. Now, a working group under the auspices of the WHO and appointed by the International Agency for Research on Cancer (IARC), ...
Jun 1, 2018
0
30
A clinical trial testing a new treatment combination in patients with leukaemia launches through the Combinations Alliance, a joint initiative between Cancer Research UK and the Experimental Cancer Medicine Centres (ECMC) ...
May 30, 2018
0
3
The key genetic events responsible for initiating the early stages of a type of childhood leukaemia have been identified by scientists at The Institute of Cancer Research, London. Insights into the 'founder' genetic mutation ...
Apr 5, 2018
0
22
Acute myeloid leukaemia is the most common type of acute cancer of the blood and bone marrow in adults. AML progresses quickly and only 26 percent of the patients survive longer than five years as resistance against established ...
Feb 23, 2018
0
6
Adults with acute lymphoblastic leukaemia living in deprived areas of England have poorer survival rates, a new study has found.
Feb 1, 2018
0
1
When people think of leukaemia, they usually think of blood cancers that affect children. These mostly come under the category of acute lymphoblastic leukaemia – or ALL – and are different to the group of blood cancers ...
Jan 16, 2018
0
9
Patients with an aggressive form of leukaemia, currently ineligible for any type of targeted therapy, may in fact benefit from some of these new drugs, according to new research by Queen Mary University of London.
Jan 9, 2018
0
1